
The Clinical Research and Equipment is pretty flat in the last 7 days, but EirGenix has stood out, gaining 3.6%. As for the longer term, the industry has declined 7.1% in the last year.
Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 22 Jun 2026 | NT$31.9b | NT$2.7b | -NT$747,832,000.00 | 20.7x | -42.6x | 12x |
| Wed, 20 May 2026 | NT$32.2b | NT$2.7b | -NT$746,869,000.00 | 21.1x | -43.1x | 12.1x |
| Fri, 17 Apr 2026 | NT$34.5b | NT$2.5b | -NT$767,980,000.00 | 21.9x | -44.9x | 13.8x |
| Sun, 15 Mar 2026 | NT$31.4b | NT$2.5b | -NT$747,966,000.00 | 19.8x | -42x | 12.5x |
| Tue, 10 Feb 2026 | NT$33.2b | NT$2.4b | -NT$689,929,000.00 | 23.9x | -48.1x | 13.7x |
| Thu, 08 Jan 2026 | NT$33.7b | NT$2.4b | -NT$689,929,000.00 | 25.3x | -48.9x | 13.9x |
| Sat, 06 Dec 2025 | NT$37.9b | NT$2.4b | -NT$670,921,000.00 | 19.6x | -56.5x | 15.5x |
| Mon, 03 Nov 2025 | NT$35.8b | NT$2.5b | -NT$870,437,000.00 | 18.4x | -41.1x | 14.6x |
| Wed, 01 Oct 2025 | NT$38.1b | NT$2.5b | -NT$870,437,000.00 | 20x | -43.7x | 15.5x |
| Fri, 29 Aug 2025 | NT$34.9b | NT$2.5b | -NT$819,216,000.00 | 20.5x | -42.6x | 14.2x |
| Sun, 27 Jul 2025 | NT$34.9b | NT$2.5b | -NT$600,003,000.00 | 21.9x | -58.1x | 14.2x |
| Tue, 24 Jun 2025 | NT$33.1b | NT$2.5b | -NT$600,003,000.00 | 22.8x | -55.1x | 13.4x |
| Thu, 22 May 2025 | NT$32.3b | NT$2.5b | -NT$604,301,000.00 | 23.2x | -53.5x | 13.2x |
| Sat, 19 Apr 2025 | NT$31.6b | NT$2.5b | -NT$540,128,000.00 | 24.3x | -58.5x | 12.8x |
| Mon, 17 Mar 2025 | NT$36.1b | NT$2.6b | -NT$849,328,000.00 | 29.2x | -42.5x | 14x |
| Wed, 12 Feb 2025 | NT$38.0b | NT$2.6b | -NT$854,432,000.00 | 23.5x | -44.4x | 14.8x |
| Fri, 10 Jan 2025 | NT$35.9b | NT$2.6b | -NT$854,432,000.00 | 23.2x | -42x | 14x |
| Sun, 08 Dec 2024 | NT$40.7b | NT$2.6b | -NT$854,432,000.00 | 23.8x | -47.6x | 15.9x |
| Tue, 05 Nov 2024 | NT$42.8b | NT$2.5b | -NT$712,402,000.00 | 24.4x | -60.1x | 17.1x |
| Thu, 03 Oct 2024 | NT$41.9b | NT$2.3b | -NT$836,610,000.00 | 22.3x | -50x | 18.4x |
| Sat, 31 Aug 2024 | NT$41.6b | NT$2.3b | -NT$836,610,000.00 | 22.2x | -49.7x | 18.3x |
| Mon, 29 Jul 2024 | NT$42.7b | NT$2.1b | -NT$797,765,000.00 | 33x | -53.5x | 20x |
| Wed, 26 Jun 2024 | NT$42.0b | NT$2.1b | -NT$797,765,000.00 | 33.9x | -52.7x | 19.7x |
| Fri, 24 May 2024 | NT$40.0b | NT$2.1b | -NT$797,765,000.00 | 32.1x | -50.1x | 18.7x |
| Sun, 21 Apr 2024 | NT$38.2b | NT$2.1b | -NT$923,759,000.00 | 30x | -41.4x | 18.1x |
| Tue, 19 Mar 2024 | NT$39.8b | NT$2.1b | -NT$611,433,000.00 | 32.2x | -65x | 19.3x |
| Thu, 15 Feb 2024 | NT$43.0b | NT$2.1b | -NT$610,218,000.00 | 32.4x | -70.4x | 20.7x |
| Sat, 13 Jan 2024 | NT$44.9b | NT$2.1b | -NT$610,218,000.00 | 33.3x | -73.6x | 21.6x |
| Mon, 11 Dec 2023 | NT$48.2b | NT$2.1b | -NT$610,218,000.00 | 33.6x | -79.1x | 23.2x |
| Wed, 08 Nov 2023 | NT$49.5b | NT$2.2b | -NT$497,769,000.00 | 32.3x | -99.4x | 22.2x |
| Fri, 06 Oct 2023 | NT$48.9b | NT$2.2b | -NT$497,769,000.00 | 31.3x | -98.3x | 22x |
| Sun, 03 Sep 2023 | NT$43.9b | NT$2.2b | -NT$497,769,000.00 | 31.8x | -88.2x | 19.7x |
| Tue, 01 Aug 2023 | NT$47.5b | NT$2.5b | -NT$274,767,000.00 | 43x | -172.8x | 19.4x |
| Thu, 29 Jun 2023 | NT$50.1b | NT$2.5b | -NT$274,767,000.00 | 43.3x | -182.4x | 20.4x |
-182.4x
How does Taiwanese Clinical Research and Equipment compare with similar industries?
| TW Market | 5.27% | |
| Healthcare | 5.72% | |
| Life Sciences | 0.82% | |
| Clinical Research and Equipment | 0.82% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6891 Locus Cell | NT$50.00 | 11.0% +NT$990.2m | 137.5% | PS785.2x | |
| 6589 EirGenix | NT$46.45 | 2.9% +NT$393.4m | -25.8% | PS12.4x |